InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Discover the full record of transactions filed by VAGELOS P ROY, Director. Director active across 1 companies, notably Regeneron Pharmaceuticals, INC.. Aggregated, 10 disclosures have been logged. Total volume traded: €9m. The latest transaction was filed on 30 March 2022 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations10 total
€9m14,286 shares@ €627.15490.012% mcap20.3% of flow
Common Stock
SEC:0001883850-22-000031:0·
€12m75,000 shares@ €163.85740.017% mcap27.9% of flow
Common Stock
SEC:0001883850-22-000020:0·
€10,68119 shares@ €562.14110.0000% mcap0.1% of flow
Common Stock
SEC:0001883850-21-000032·
€10,68119 shares@ €562.14110.0000% mcap0.0% of flow
Common Stock
SEC:0001883850-21-000032:0·
01,861 shares0
Common Stock
SEC:0001708138-21-000094·
01,861 shares0
Common Stock
SEC:0001708138-21-000094:0·
€11m75,000 shares@ €152.13510.016% mcap99.9% of flow
Common Stock
SEC:0001708138-21-000066·
€11m75,000 shares@ €152.13510.016% mcap25.9% of flow
Common Stock
SEC:0001708138-21-000066:0·
022,000 shares0
Common Stock
SEC:0001708138-21-000062·
022,000 shares0
Common Stock
SEC:0001708138-21-000062:0·
10 of 10 declarations
About VAGELOS P ROY
Roy P. Vageos is a Board Member of REGENERON PHARMACEUTICALS, INC. He contributes to the governance of the company, bringing his experience in the pharmaceutical sector to guide strategic decisions.
